Abstract:Protein kinase C alpha (PKCα) can activate both pro- and anti-tumorigenic signaling depending upon cellular context. Here, we investigated the role of PKCα in lung tumorigenesis in vivo. Gene expression data sets revealed that primary human non-small lung cancers (NSCLC) express significantly decreased PKCα levels, indicating that loss of PKCα expression is a recurrent event in NSCLC. We evaluated the functional relevance of PKCα loss during lung tumorigenesis in three murine lung adenocarcinoma models (LSL-Kras, LA2-Kras and urethane exposure). Genetic deletion of PKCα resulted in a significant increase in lung tumor number, size, burden and grade, bypass of oncogene-induced senescence, progression from adenoma to carcinoma and a significant decrease in survival in vivo. The tumor promoting effect of PKCα loss was reflected in enhanced Kras-mediated expansion of bronchio-alveolar stem cells (BASCs), putative tumor-initiating cells, both in vitro and in vivo. LSL-Kras/Prkca(-/-) mice exhibited a decrease in phospho-p38 MAPK in BASCs in vitro and in tumors in vivo, and treatment of LSL-Kras BASCs with a p38 inhibitor resulted in increased colony size indistinguishable from that observed in LSL-Kras/Prkca(-/-) BASCs. In addition, LSL-Kras/Prkca(-/-) BASCs exhibited a modest but reproducible increase in TGFβ1 mRNA, and addition of exogenous TGFβ1 to LSL-Kras BASCs results in enhanced growth similar to untreated BASCs from LSL-Kras/Prkca(-/-) mice. Conversely, a TGFβR1 inhibitor reversed the effects of PKCα loss in LSL-Kras/Prkca(-/-) BASCs. Finally, we identified the inhibitors of DNA binding (Id) Id1-3 and the Wilm's Tumor 1 as potential downstream targets of PKCα-dependent tumor suppressor activity in vitro and in vivo. We conclude that PKCα suppresses tumor initiation and progression, at least in part, through a PKCα-p38MAPK-TGFβ signaling axis that regulates tumor cell proliferation and Kras-induced senescence. Our results provide the first direct evidence that PKCα exhibits tumor suppressor activity in the lung in vivo.

PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.

PRAK Is Essential for ras-Induced Senescence and Tumor Suppression

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis

Mutant Ras and Inflammation-Driven Skin Tumorigenesis is Suppressed Via a JNK-iASPP-AP1 Axis

The essential role of PRAK in tumor metastasis and its therapeutic potential

Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia

Depletion of P21-Activated Kinase 1 Up-Regulates the Immune System of APC∆14/+ Mice and Inhibits Intestinal Tumorigenesis

Rheb phosphorylation is involved in p38-regulated/activated protein kinase-mediated tumor suppression in liver cancer.

Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis

PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Deregulated PP1α Phosphatase Activity Towards MAPK Activation is Antagonized by a Tumor Suppressive Failsafe Mechanism

The PRAK-NRF2 Axis Promotes the Differentiation of Th17 Cells by Mediating the Redox Homeostasis and Glycolysis.

Essential Role of p38γ in K-Ras Transformation Independent of Phosphorylation

Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells

P38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells Through Regulation of Vitamin D Receptor

Receptor-like Protein Tyrosine Phosphatase Κ Negatively Regulates the Apoptosis of Prostate Cancer Cells Via the JNK Pathway.

Data from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Nras(G12D/+) Promotes Leukemogenesis by Aberrantly Regulating Hematopoietic Stem Cell Functions.

K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling